Heavy consumption of alcohol induces cardiomyopathy and is associated with metabolic changes in the heart. The role of altered metabolism in the development of alcoholic cardiomyopathy remains largely unknown but is examined in the present study. The effect of chronic alcohol consumption on cardiac damage was examined in mice fed an alcohol or isocaloric control diet for 2 months. Signaling pathways of alcohol-induced metabolic alteration and pathologic changes were examined in both animal hearts and H9c2 cell cultures. Compared with controls, the hearts from the alcohol-fed mice exhibited cardiac oxidative stress, cell death, a fibrotic response, hypertrophic remodeling, and the eventual development of cardiac dysfunction. All these detrimental effects could be ameliorated by superoxide dismutase mimic Mn (111) tetrakis 1-methyl 4-pyridylporphyrin pentachloride (MnTMPyP) therapy. A mechanistic study showed that chronic alcohol exposure enhanced the expression of proteins regulating fatty acid uptake but impaired the expression of proteins involved in mitochondrial fatty acid oxidation, which compensatively geared the heart to the suboptimal energy source, glucose. However, chronic alcohol exposure also impaired the glycolytic energy production step regulated by glyceraldehyde-3-phosphate dehydrogenase, which further feeds back to enhance glucose uptake signaling and the accumulation of glycolytic intermediate product fructose, resulting in aggravation of alcohol-induced cardiac oxidative stress, cell death, and remodeling. All these dysmetabolic alterations could be normalized by MnTMPyP treatment, along with significant improvement in cardiac cell death and remodeling. These results demonstrate that alcohol-induced oxidative stress and altered glucose metabolism are causal factors for the development of alcoholic cardiomyopathy.
Regular heavy consumption of alcohol is associated with alcoholic cardiomyopathy, a nonischemic cardiomyopathy that is characterized by cardiac hypertrophy, fibrotic remodeling, and systolic dysfunction (Piano and Phillips, 2014) . Alcoholic cardiomyopathy contributes to approximately one-fifth of all sudden cardiac deaths (Hookana et al., 2011) . Several theories have been proposed to explain the initiation and development of alcoholic cardiomyopathy, including oxidative stress, accumulation of triglycerides, altered fatty acid (FA) oxidation, decreased myofilament Ca 2þ sensitivity, and impaired protein synthesis (Cai, 2008; Zhang et al., 2004) . However, a generally accepted hypothesis behind alcoholic cardiac damage proposes that excessive alcohol-induced oxidative stress is a key to cardiac cell death and dysfunction (Cai, 2008) . Our studies and those of others have demonstrated the critical role of oxidative stress and damage caused by acute and chronic consumption of alcohol in alcoholic cardiomyopathy (Aroor et al., 2012; Jing et al., 2012; Li and Ren, 2006a; Tan et al., 2012; Zhang et al., 2003) and that endogenous antioxidative enzymes are able to protect against alcoholic cardiomyopathy (Li and Ren, 2006b; Wang et al., 2005; Zhang et al., 2003 Zhang et al., , 2005 . For example, Li and Ren demonstrated that transgenic overexpression of metallothionein (MT) (Li and Ren, 2006b ), a nonspecific scavenger of reactive oxygen species and reactive nitrogen species, can ameliorate cardiac function in mice that received chronic intake of alcohol for 12 weeks (Li and Ren, 2006a) or 16 weeks (Li and Ren, 2006b ). Wang et al. found that chronic intake of alcohol caused more severe cardiac fibrosis and oxidative damage in the hearts of MT-null mice than in wild-type mice (Wang et al., 2005) . Furthermore, cardiac-specific overexpression of catalase, another antioxidative enzyme that catalyzes degradation of hydrogen peroxide, also showed resistance to alcohol-induced cardiac dysfunction (Zhang et al., 2003 (Zhang et al., , 2005 .
It has been observed that alcohol consumption is prone to alter energy metabolism in multiple organs (Fischer et al., 2003; Sozio and Crabb, 2008) . For example, chronic alcohol feeding impairs FA catabolism in the liver (Fischer et al., 2003) and heart (Piano and Phillips, 2014; Zhang et al., 2004) . Metabolic disorder plays a causative role in cardiac cell death and remodeling (Varga et al., 2015) , but how chronic alcohol consumptioninduced cardiac oxidative stress triggers metabolic disorder contributing to cardiac damage remains largely unknown.
The heart is known for its ability to produce energy from FA because of its important beta-oxidation equipment, but it can also derive energy from several other substrates, including glucose, pyruvate, and lactate under certain pathophysiological conditions (Grynberg and Demaison, 1996) . Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a critical enzyme in the glycolytic breakdown of glucose and catalyzes the conversion of glyceraldehyde 3-phosphate (GADP) to D-glycerate 1,3-bisphosphate. Excessive oxidative stress induces irreversible oxidation of GAPDH cysteine residues, resulting in inhibition of its enzymatic activity (Pierce et al., 2008) . Whether chronic alcohol consumption-induced oxidative stress affects GAPDH-mediated glucose metabolism, and whether this effect further aggravates cardiac oxidative stress, cell death, and eventual development of alcoholic cardiomyopathy, have not been well-defined. Herein, we investigated the effects of chronic alcohol exposure on cardiac energy metabolism and defined the potential roles of GAPDH in the development of alcoholic cardiomyopathy using a chronic alcohol consumption model in mice and H9c2 cell cultures exposed to alcohol.
METHODS AND MATERIALS
Animals and alcohol feeding. The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health. All procedures were approved by the Institutional Animal Care and Use Committee of the University of Louisville, which is certified by the American Association for Accreditation of Laboratory Animal Care. Male C57BL/6 mice were obtained from the Jackson Laboratory (Bar Harbor, Maine). For all animal studies on chronic alcohol exposure, 4-month-old male mice were pair-fed a modified LieberDeCarli alcohol or isocaloric maltose dextrin control liquid diet for 2 months with a stepwise feeding procedure as described in our previous report (Tan et al., 2012) . The ethanol content (%, wt/vol) in the diet was 4.8 (34% of total calories) at initiation, and gradually increased up to 5.4 (38% of total calories). The amount of food given to the pair-fed mice was matched to that of the alcohol-fed mice measured on the previous day. After heart function detection (echocardiography) at the end of the experiments, mice were anesthetized and sacrificed, and hearts were collected for protein, mRNA, and histopathological examination.
The effect of chronic alcohol consumption on the heart was investigated in the first animal study. Therefore, these 8 control mice and 11 alcohol-treated mice did not receive any additional treatment. For the second animal study, except for the alcohol feeding, these mice were simultaneously treated with superoxide dismutase (SOD) mimic MnTMPyP [Mn (111) tetrakis 1-methyl 4-pyridylporphyrin pentachloride, purchased from Sigma Chemical Co, St. Louis, Missouri] at 5 mg/kg body weight daily for 2 months; n ! 8 for each group.
Cell cultures. The H9c2 rat cardiac cell line was purchased from American Type Cell Collection (ATCC, Manassas, Virginia) and cultured in Dulbecco's Modified Eagle's Medium (DMEM) (Mediatech, Inc, Manassas, Virginia) supplemented with 10% fetal bovine serum (Invitrogen, Carlsbad, California) . H9c2 cells in all the experiments were in passages between 3 and 15. The effects of different doses of ethanol (0.625%-2.5% vol/vol, approximately 100-400 mmol/l) exposure for 24 h on fibrosis, cell death, oxidative damage, and glucose and lipid metabolism were examined initially. In subsequent studies, exposure to ethanol at 1.25% vol/vol (approximately 200 mmol/l) for 24 h was selected after pretreatment with 50 mmol/l MnTMPyP (Sigma Chemical Co).
Echocardiography. Under sedation with tribromoethanol (0.25 mg/g, intraperitoneally), 2D, M-mode, and Doppler echocardiography were performed using a Philips SONOS 5500 highperformance ultrasound system and a 15-6L linear array (15 MHz) transducer (120 Hz frame rate) as previously described Zhang et al., 2015) . Left ventricular (LV) systolic function was assessed by ejection fraction (EF, %) and fraction shortening (FS, %).
Sirius red staining of collagen. Cardiac fibrosis was examined by Sirius Red staining of collagen accumulation as described in our previous studies (Bai et al., 2013; Tan et al., 2012; Yan et al., 2015; Zhang et al., 2015) . Briefly, tissue sections of 5 lm were used for Sirius Red staining of collagen using 0.1% Sirius Red F3BA and 0.25% Fast Green FCF. The sections stained for Sirius Red were then assessed for the proportion of fibrosis using a Nikon Eclipse E600 microscopy system as described in our previous studies (Bai et al., 2013; Tan et al., 2012; Yan et al., 2015; Zhang et al., 2015) . The positive area of Sirius Red staining was normalized to the control.
Transferase-mediated dUTP nick-end labeling staining. Apoptotic nuclei in the heart were examined by transferase-mediated dUTP nick-end labeling (TUNEL) staining using the Apop Tag In Situ kit (Chemicon, Temecula, California). Heart tissue was fixed in buffered neutral 10% formalin, dehydrated in a graded alcohol series, embedded in paraffin, and sectioned at 5 lm. Deparaffinized and hydrated slides were used for TUNEL staining according to the manufacturer's instructions. TUNEL positive nuclei were counted under high magnification (20Â) in 10 random fields for each of 5 slides from 1 mouse, and presented as TUNEL positive nuclei per 10 6 cardiac cell nuclei.
GAPDH activity assay. The KDalert GAPDH Assay Kit (Applied Biosystems, Austin, Texas) was used to detect the GAPDH activity of heart tissues and H9c2 cells according to the manufacturer's instructions. Briefly, 20 mg heart tissues or 1 Â 10 4 H9c2 cells were lysed using the one-step lysis/assay buffer and incubated at 4 C for 20 min, 10 ll of cell lysate was transferred to a 96-well plate and 90 ll of KDalert Master Mix was added to each well. The increase in fluorescence at room temperature was measured using a SpectraMax 190 Absorbance Microplate Reader (Molecular Devices, California) using an excitation wavelength of 560 nm and emission wavelength of 590 nm.
Fructose assay. Fructose content in heart tissues or H9c2 cells was assayed by the Fructose Assay Kit (BioVision, Inc, Mountain View, California) according to the manufacturer's instructions.
Western blot. Western blots were performed according to our previous studies Yan et al., 2015; Zhang et al., 2015) . Briefly, heart tissues or harvested cells were homogenized or lysed in RIPA buffer (Santa Cruz Biotechnology, Dallas, Texas). Total protein was extracted and separated on 10% SDS-PAGE gels and transferred to a nitrocellulose membrane (BioRad, Hercules, California). The membrane was blocked with a 5% nonfat, dry milk solution for 1 h and then incubated overnight at 4 C with the following antibodies: cleaved caspase-3
(1:1000), p-Akt (1:1000), Akt (1:1000), phosphor-glycogen synthase kinase-3b (p-GSK-3b, 1:1000), GSK-3b (1:3000) (Cell Signaling Technology, Danvers, Massachusetts), Fibronectin (1:1000), TGF-b (1:1000), CTGF (1:1000), PPARa (1:1000), Hexokinase II (HKII, 1:1000), GAPDH (1:5000) (Santa Cruz Biotechnology), 3-nitrotyrosine (3-NT, 1:2000, Chemicon), TGF-b (1:1000), b-actin (1:3000), PAI-1(1:4000) (BD Biosciences, San Jose, California), or PGC1-a (1:4000) (Abcam, Cambridge, Massachusetts). After 3 washes with Tris-buffered saline (pH 7.2) containing 0.05% Tween 20, membranes were incubated with the appropriate secondary antibodies for 1 h at room temperature. Antigen-antibody complexes were visualized with enhanced chemiluminescence. The expression of specific antigens was quantified using the ImageQuant 5.2 software (Molecular Dynamics, Inc, Sunnyvale, California). The expression of b-actin was used as a loading control except where indicated, and the results were presented as fold of control.
Statistical analysis. Data were collected from repeated experiments and presented as the mean 6 SD. For statistical analysis, one-way or two-way analysis of variance was used with overall F-test analysis for the significance of the analysis of variance.
Multiple comparisons were then performed using the Bonferroni test with Origin 7.5 Lab data analysis and graphing software.
RESULTS

Alcohol Induces Cardiac Hypertrophy and Dysfunction
Chronic alcohol consumption slightly decreased body weight ( Figure 1A ), but significantly increased heart weight ( Figure 1B) , heart weight to body weight ratio ( Figure 1C ) and heart weight to tibia length ratio ( Figure 1D ), indicating that chronic alcohol exposure induced cardiac hypertrophy in mice. Echocardiography further confirmed the increment in left ventricle mass ( Figure 1E ). Moreover, echocardiography results showed that chronic alcohol intake induced a decrement in EF ( Figure 1F ) and FS ( Figure 1G ), both of which indicate an impairment in LV systolic function.
Alcohol Induces Cardiac Cell Death, Oxidative Stress and Fibrotic Remodeling Cardiac cell death is a major cause of cardiac dysfunction (Tan et al., 2012; Zhou et al., 2008) . Apoptotic cell death in the heart was examined by TUNEL staining. More apoptotic cells were observed in the hearts of alcohol-fed mice than in control mice (Figs. 2A and B) . Western blot results also showed that cleaved caspase-3 (Figs. 2C and D) was significantly increased after alcohol feeding, which further confirmed that chronic alcohol exposure induced cardiac cell apoptosis. Alcohol-induced cardiac cell death was accompanied by significant cardiac oxidative damage, mirrored by a significant increase in 3-NT modification of multiple cardiac proteins (22-98 kDa) (Figs. 2E and F).
Chronic cardiac cell death triggers cardiac remodeling (Tan et al., 2012; Zhou et al., 2008) . Therefore, cardiac fibrotic remodeling was examined in this model. Sirius Red staining results showed that chronic alcohol exposure significantly induced collagen accumulation in the heart (Figs. 3A and B) . The elevated expression of fibronectin ( Figure 3C ), TGF-b1 ( Figure 3D ) and CTGF ( Figure 3E ) in the hearts of alcohol-fed mice further confirmed that chronic alcohol intake induced cardiac fibrotic remodeling.
Alcohol Impairs Cardiac Lipid and Glucose Utilization
The cardiac lipid and glucose metabolic status after alcohol exposure were investigated by detecting the critical proteins in regulating lipid and glucose metabolism. Cardiac expression of PPARa, a positive mediator for FA uptake and oxidation (Finck et al., 2002) , was increased in the alcohol-fed mice ( Figure 4A ), indicating an increased lipid uptake and utilization after alcohol exposure. However, the expression of PGC-1a, an essential regulator for the maintenance of maximal and efficient cardiac mitochondrial FA oxidation (Lehman et al., 2008) , was significantly depressed in the alcohol-fed mice hearts ( Figure 4B ). These results demonstrated that cardiac FA metabolism was impaired after chronic alcohol exposure.
Activation of Akt and GSK-3b is essential for glucose metabolism (Palomer et al., 2013) . Therefore, the phosphorylation of Akt and GSK-3b were used to evaluate cardiac glucose metabolism. In alcohol-fed mice hearts, the phosphorylation of Akt ( Figure  4C ) and GSK-3b ( Figure 4D ) were both obviously up-regulated. Moreover, the expression of HKII, a critical enzyme in glucose phosphorylation to glucose 6-phosphate for further glycolysis, was also up-regulated in alcohol-fed mice hearts ( Figure 4E) . These results indicate a more active cardiac glycolysis after alcohol exposure.
To further confirm the cardiac glycolytic status, GAPDH, a critical enzyme in the glycolytic breakdown of glucose producing energy-rich molecules, was also investigated in the alcohol- weight to body weight ratios (C), heart weight to tibia length ratios (D) and left ventricle mass (F) of chronic alcohol-fed mice (Alcohol) were compared with control mice (Ctrl). Cardiac function was evaluated by ejection fraction (EF, F) and fraction shortening (FS, G) using echocardiography. n ¼ 8 for the Ctrl group; n ¼ 11 for the alcohol group. Data shown in graphs represent the means 6 SD. *P < .05 versus Ctrl group. fed mice hearts. The results showed that the expression of GAPDH, at both the mRNA and protein levels, was down-regulated (Figs. 4F and G), along with a significant inhibition of its enzymatic activity ( Figure 4H ) after chronic alcohol exposure, indicating a glycolytic energy production impairment.
The impairment of glycolysis usually leads to the activation of compensatory glucose metabolism pathways, such as the sorbitol pathway (also named sorbitol-aldose reductase pathway) (Obrosova, 2005) and the hexosamine pathway (Du et al., 2000) . We detected the content of fructose, the final product of the sorbitol pathway, and found that chronic alcohol feeding significantly enhances cardiac fructose accumulation ( Figure  4I ), which further confirmed cardiac glucose metabolism impairment after chronic alcohol consumption.
Alcohol Treatment Induces Apoptosis, Oxidative Stress, and a Fibrotic Response, and Impairs Lipid and Glucose Utilization in H9c2 Cells
To exclude the indirect effect of alcohol and its metabolites on the hearts in vivo, cardiac H9c2 cells were treated with alcohol at concentrations of 0.625%, 1.25% and 2.5% (vol/vol). Alcohol exposure for 24 h obviously induced cardiac cell death, oxidative stress, and the fibrotic response in a dose-dependent manner, indicated by the elevated expression of cleaved caspase-3 ( Figure 5A ), major protein tyrosine nitration ( Figure 5B ), and CTGF expression ( Figure 5C ), respectively. Similarly, the critical proteins involved in lipid and glucose metabolism were also altered in H9c2 cells after alcohol exposure. PGC1-a expression was decreased ( Figure 6A ), whereas the phosphorylation of Akt ( Figure 6B ) and GSK-3b ( Figure 6C ), and the expression of HKII ( Figure 6D ) were elevated dose-dependently in alcohol treated cardiac cells. Consistent with that in cardiac tissues of alcohol-fed mice, the expression and activity of GAPDH were both repressed in alcohol-treated H9c2 cardiac cells in a dosedependent manner (Figs. 6E and F) , along with a dosedependent accumulation of fructose ( Figure 6G ). All these changes induced by alcohol exposure in cardiac cells recaptured their changing profiles in cardiac tissues of alcohol-fed mice, indicating that this in vitro model could be used for further mechanistic study.
MnTMPyP Prevents Alcohol-Induced Cardiac Damage
To determine the causative role of oxidative stress in alcoholinduced cardiac damage, the SOD mimetic MnTMPyP, a potent antioxidant reagent, was induced to scavenge the alcoholinduced excessive oxidative stress in vitro and in vivo. In H9c2 cardiac cells, MnTMPyP pretreatment significantly prevented alcohol-induced cardiac cell death, indicated by the decrease in caspase-3 cleavage ( Figure 7A ), along with preservation of cardiac lipid and glucose metabolism, mirrored by normalization of PGC1-a expression ( Figure 7B ), GSK-3b phosphorylation ( Figure 7C ), GAPDH expression ( Figure 7D ) and enzymatic activity ( Figure 7E) , and fructose accumulation ( Figure 7F ). Most importantly, the protective effects of MnTMPyP on alcoholic cardiac damage were also completely recaptured in the in vivo study. MnTMPyP administration significantly prevented alcohol-induced cardiac hypertrophy ( Figure 8A ), cell death Figure 8D ), and normalized cardiac GAPDH enzymatic activity ( Figure 8E ) and fructose accumulation ( Figure 8F ).
DISCUSSION
Several theories have been proposed to explain the mechanism of alcoholic cardiomyopathy, and we herein focus on the metabolic aspect. Here, we demonstrated that chronic alcohol exposure induces cardiac oxidative stress (Figs. 2E and F) , cell death ( Figs. 2A-D) , a fibrotic response (Figure 3 ) and hypertrophic remodeling (Figs. 1B-E) , and the eventual development of alcoholic cardiac dysfunction (Figs. 1F and G) and that all these detrimental effects could be ameliorated by the SOD mimic MnTMPyP therapy (Figs. 8A-F) , indicating that oxidative stress plays a causative role in the development of alcoholic cardiomyopathy ( Figure 8G ). The mechanistic study showed that chronic alcohol exposure impairs cardiac FA utilization (Figs. 4A and B and 6A), which causes a compensatory response of the hearts to change to a suboptimal energy source, glucose (Figs. 4C-E and 6B-D). However, chronic alcohol exposure also impairs the glycolytic energy production step regulated by GAPDH (Figs. 4F-H and 6E and F), which further feeds back to enhance glucose uptake and the accumulation of the glycolytic intermediate product, fructose (Figs. 4I and 6G) , resulting in aggravation of alcohol-induced cardiac oxidative stress, cell death, remodeling, and dysfunction ( Figure 8G ) (Mirtschink et al., 2015) .
The first innovative finding here is that chronic alcohol consumption enhances cardiac lipid and glucose uptake but impairs their efficient utilization. In normal hearts, 70% of ATP generation is through FA oxidation, whereas glucose and lactate account for $30% of energy provided to the cardiac muscle (An and Rodrigues, 2006 ; van der Vusse et al., 1992). The effects of Figure 6 . Alcohol treatment impairs the lipid and glucose utilization of H9c2 cells in vitro. H9c2 cells were exposed to alcohol as described in Figure 5 . The expression of PGC-1a (A) was detected by Western blot to evaluate lipid utilization.
The phosphorylation of Akt (B) and GSK-3b (C), the expression of HKII (D) and GAPDH (E), the activity of GAPDH (F), and fructose accumulation (G) were detected to reflect cardiac glucose utilization. Three independent experiments were performed. Data shown in graphs represent the means 6 SD. *P < .05 versus vehicle Ctrl (0) group. and GAPDH (D), and the phosphorylation of GSK-3b (C) were detected by Western blot. GAPDH activity (E) and fructose content (F) were detected by using the KDalert GAPDH Assay Kit or the Fructose Assay Kit, respectively. Three independent experiments were performed. Data shown in graphs represent the means 6 SD. *P < .05 versus vehicle Ctrl (0) group; #P < .05 versus 1.25% alcohol group. chronic alcohol exposure on cardiac FA and glucose metabolism remain largely unknown. PPARa plays a critical role in regulating the predilection of cardiomyocytes for an energy source. In mice with cardiac-restricted overexpression of PPARa (MHC-PPAR), myocardial FA uptake and oxidation were increased and glucose uptake and oxidation decreased (Finck et al., 2002) . In alcohol-fed mice hearts in the present study, PPARa expression was dramatically up-regulated ( Figure 4A ), implying an increase in myocardial FA uptake. However, the expression of PGC1-a ( Figure 4B ), a regulator that is essential for maximal and efficient cardiac mitochondrial FA oxidation and lipid homeostasis, was obviously down-regulated, indicating an impaired FA oxidation and utilization.
Activation of Akt is essential for almost all insulin-induced glucose metabolism, such as glucose uptake, glycogen synthesis, and suppression of triglyceride synthesis (Palomer et al., 2013) . Akt regulates glycogen synthesis via phosphorylation of the predominant regulator of glycogen synthase, GSK-3b (Markou et al., 2008; Patel et al., 2008) . Unlike most protein kinases, GSK-3b remains active in its dephosphorylated form and is inactivated upon phosphorylation by other protein kinases, such as Akt (Wang et al., 2009) . The activity and effects of Akt on glucose metabolism in alcohol-fed mice hearts remains controversial. Zhou et al. (2002) found C57BL/6 mice fed with 18% alcohol (vol/vol) in drinking water for 12 weeks exhibited enhanced phosphorylation of Akt and GSK-3b in cardiac tissues, whereas Figure 8 . MnTMPyP ameliorates alcohol-induced cardiac damage. Pair-fed and alcohol-fed mice were treated with and without MnTMPyP at 5 mg/kg body weight daily for 2 months. Cardiac hypertrophy was evaluated by measuring heart weight to tibia length ratio (A), cardiac cell apoptosis was detected by TUNEL stain (B and C), and fibrosis was detected by Sirius Red staining of collagen accumulation (D). Cardiac GAPDH enzymatic activity (E) and fructose accumulation (F) were detected by using the KDalert GAPDH Assay Kit or the Fructose Assay Kit, respectively. A mechanistic illustration of how MnTMPyP ameliorates alcoholic cardiomyopathy (G): Alcohol consumption aggravates oxidative stress, which inhibits the expression and enzymatic activity of GAPDH. The repressed GAPDH activity impairs glucose utilization and activates the compensatory polyol pathway, which then leads to fructose accumulation and further aggravates oxidative stress in cardiomyocytes. The elevated oxidative stress induces cardiac cell apoptosis and finally results in cardiomyopathy. Antioxidants, such as MnTMPyP, can restore the activity of GAPDH and normalize glucose and lipid metabolism, which further attenuates cell apoptosis and ameliorates cardiomyopathy. n ! 8 for each group. *P < .05 versus Ctrl group; #P < .05 versus alcohol group. Ren, 2007, 2008) found that alcohol reduced the phosphorylation of Akt and GSK-3b in cardiomyocytes of FVB mice fed a 4% alcohol diet for the same period. The work of Umoh et al. (2014) revealed that acute, low-dose alcohol reduced, but high-dose alcohol enhanced, Akt activity in a compensatory manner. The influence of alcohol on the Akt/GSK-3b pathway may be determined by the final cardiac content of alcohol. In the present study, the phosphorylation of Akt and GSK-3b in the heart (Figs. 4C and D) and H9c2 cells (Figs. 6B and C) that received alcohol exposure was found to be elevated. These results indicate that glucose uptake is more active in alcoholic hearts and alcohol-treated H9c2 cells.
Glycolysis is said to occur in 2 phases: (1) the preparatory phase (steps 1-5), characterized by energy consuming to convert the glucose into GADP and (2) the pay-off phase (steps 6-10), characterized by a net gain of the energy-rich molecules ATP and NADH by converting GADP into the final product pyruvate. The preparatory phase is initiated by HKII upon Akt dephosphorylation of GSK-3b (Miyamoto et al., 2008; Pastorino et al., 2005) , whereas the pay-off phase is initiated by GAPDH. Whether the up-regulated glucose uptake leads to more efficient glycolytic utilization remains unknown. Here, we found that the expression of HKII was elevated in alcoholic hearts and alcohol-treated H9c2 cells (Figs. 4E and 6D) , which indicates the preparatory phase of cardiac glycolysis is also up-regulated after alcohol exposure. However, the expression and activity of GAPDH is inhibited by chronic alcohol exposure (Figs. 4G and H and 6E and F) , resulting in the accumulation of the intermediate product in glycolysis and activation of the compensatory polyol pathway reflected by enhanced fructose accumulation (Figs. 4I and 6G) . This is the first direct evidence to show that chronic alcohol exposure enhances cardiac glucose uptake, but impairs glycolytic utilization.
The enhancement of cardiac FA and glucose uptake, and impairment of their oxidation, may further aggravate alcoholinduced oxidative stress (Zhang et al., 2004) , evidenced by elevated 3-NT modification ( Figure 2E ), and the eventual development of alcoholic cardiomyopathy (Figs. 1-3) .
It should be mentioned that in addition to regulating glycolysis, GAPDH is also considered a critical molecule in regulating cell apoptosis (Chuang et al., 2005; Dastoor and Dreyer, 2001; Sawa et al., 1997; Sirover, 1997 Sirover, , 2005 . Oxidative stress may induce irreversible oxidation of GAPDH cysteine residues, promote intermolecular disulfide bond formation, and induce insoluble amyloid-like GAPDH aggregates that promote cell death (Colell et al., 2009) . Whether alcohol-induced oxidative stress (Figs. 2E and 5B) triggers cardiac cell death (Figs. 2A-D and 5A) via inducing GAPDH aggravation will be the subject of a future study.
The second innovative finding in the present study is that, as a potent antioxidant SOD mimic, MnTMPyP can improve alcohol exposure-impaired cardiac glucose metabolism and prevent alcohol-induced cardiac damage. Our previous study has demonstrated that MnTMPyP prevents alcohol-induced cardiac cell death and remodeling in mice (Tan et al., 2012) , but whether MnTMPyP treatment can normalize cardiac glucose metabolism remains unknown. Here, we provided the first evidence that MnTMPyP, by attenuating oxidative stress, preserves cardiac glucose utilization, reflected by normalization of Akt/GSk-3b-mediated glucose uptake signaling (Figs. 7C and F and 8F) and GAPDH-mediated glucose glycolytic signaling (Figs. 7D and E and 8E) both in vitro and in vivo, contributing to the attenuation of cardiac cell death (Figs. 7A and 8B) and cardiac remolding (Figs. 8A and D) .
In summary, chronic alcohol exposure enhances oxidative stress and results in cardiomyocyte apoptosis, fibrotic remolding and cardiac dysfunction, which may be attributed to the repressed enzymatic activity of GAPDH and impaired cardiac glycolysis. MnTMPyP treatment can attenuate these alcoholinduced detrimental effects. These findings indicate a critical role of GAPDH in the development of alcoholic cardiomyopathy and provide a novel therapeutic target for preventing alcoholinduced cardiac damage via heart metabolic intervention with antioxidant therapy.
